Quantum BioPharma Ltd. (NasdaqCM: QNTM)
Health Care · Pharmaceuticals · CA
$3.85
+5.19% today · -76.2% 1Y
Quantum BioPharma Ltd. (NasdaqCM: QNTM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $31.14M and employs 17 people.
Over the last twelve months the share price has lost 76.2%, trading between 2.07 and 19.30.
Tweenvest scores Quantum BioPharma Ltd. across four factors: quality 39/100, value 56/100. Its strongest factor is value.
QNTM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.14M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -5.35
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- $19.30
- 52-week low
- $2.07
- Avg volume (3M)
- —
- Shares outstanding
- 8.09M
- Employees
- 17
- Next earnings
- —
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development. Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings. A flagship asset is Lucid-MS, a novel, proprietary chemical entity currently in Phase 2 clinical trials. Preclinical data indicates its potential to prevent and reverse the degradation of myelin, a key process underlying multiple sclerosis. Furthermore, Quantum BioPharma is developing a therapeutic solution for alcohol addiction, intended for application in hospital and clinical environments. The company's strategic investments portfolio includes various loans collateralized by residential real estate. Previously known as FSD Pharma Inc., the company adopted its current name, Quantum BioPharma Ltd., in August 2024.
- ISIN
- CA74764Y2050
- Founded
- 1998
- Listed since
- Jun 8, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cilo Cybin Holdings LimitedJSE: CCC | $31.74M | R1.80 | +38.46% |
| Syntara LimitedASX: SNT | $31.69M | AU$0.02 | -8.00% |
| ZYUS Life Sciences CorporationTSXV: ZYUS | $31.42M | CA$0.55 | -8.33% |
| Sharp Therapeutics Corp.TSXV: SHRX | $31.40M | CA$1.37 | — |
| MariMed Inc.OTCPK: MRMD | $31.03M | $0.08 | +5.34% |
| New Green Hemp Inc.OTCPK: NGHI | $30.79M | $1.22 | +26.06% |
| LeonaBio, Inc.NasdaqCM: LONA | $30.62M | $3.25 | -52.14% |
| Regent Pacific Group LimitedSEHK: 575 | $30.51M | HK$0.82 | -8.38% |
Figures last refreshed Sep 20, 2026.